| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10215250 | Thrombosis Research | 2018 | 7 Pages |
Abstract
In patients treated with ticagrelor, we found no major differences between bivalirudin and heparin in platelet aggregation or coagulation markers, which is in agreement with the neutral clinical results of the VALIDATE-SWEDEHEART study.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dimitrios Venetsanos, Tomas L. Lindahl, Sofia Sederholm Lawesson, Kerstin M. Gustafsson, HÃ¥kan Wallen, David Erlinge, Eva Swahn, Joakim Alfredsson,